2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors

DOI: 10.1021/acsmedchemlett.7b00091

Keywords: Selective FGFR4 inhibitor, targeted therapy, breast cancer, hepatocellular carcinoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text